Pulse Biosciences (PLSE) Long-Term Debt Repayments (2021 - 2022)

Name: Pulse Biosciences (PLSE) Long-Term Debt Repayments (2021 - 2022) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly Long-Term Debt Repayments came in at $437000.0 in Q1 2022, down 33.49% quarter-over-quarter from $657000.0 in Q4 2021.

Pulse Biosciences has reported Long-Term Debt Repayments for 2 years, with the latest figure at $437000.0 in Q1 2022.

For the quarter ending Q1 2022, Long-Term Debt Repayments changed N/A year-over-year to $437000.0; the trailing twelve-month figure through Dec 2022 stood at $437000.0 (changed N/A YoY), and the FY2022 full-year result was $437000.0, down 71.48% from the prior year.
Long-Term Debt Repayments for Q1 2022 stood at $437000.0, down from $657000.0 in the prior quarter.
The five-year high for Long-Term Debt Repayments was $657000.0 in Q4 2021, with the low at $437000.0 in Q1 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	-
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	2.00 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	-
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	-
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	-
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	904.20 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	-
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	-
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	127.93 Mn
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	-

Download Data 🔒